医学
转移性乳腺癌
荟萃分析
药品
肿瘤科
乳腺癌
抗体-药物偶联物
曲妥珠单抗
抗体
癌症
内科学
药理学
单克隆抗体
免疫学
作者
Francesco Schettini,Sabrina Nucera,Tomás Pascual,Olga Martínez‐Sáez,Rodrigo Sánchez-Bayona,Benedetta Conte,Giuseppe Buono,Matteo Lambertini,Kevin Punie,Juan Miguel Cejalvo,Grazia Arpino,Paolo Vigneri,Daniele Generali,Eva Ciruelos,Javier Cortés,Alessandra Gennari,Montserrat Muñoz-Mateu,María Vidal,Sara M. Tolaney,Aleix Prat
标识
DOI：10.1016/j.ctrv.2024.102865
摘要
Similar efficacy with T-DXd and SG in HER2-low MBC was observed, regardless of HR status. Safety profile, local drug-approval criteria and guidelines, patients' preferences and overall quality of evidence should ultimately guide therapeutic decision-making. Dato-DXd role remains uncertain.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
热心市民小杨
penxyy
NingJi
Dr.Zhang
tiptip
橘x
从容水蓝
无极微光
干净的琦
互助
大力的灵雁
mlv
Arthur
小蘑菇
含糊的尔槐
无奈的碧彤
ceeray23
核桃
寻道图强
felyne
皖公网安备34019202002308
